As of 2026-09-17, the EV/EBITDA ratio of Precigen Inc (PGEN) is -18.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 2,728.20 mil USD. PGEN's TTM EBITDA according to its financial statements is -146.49 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 15.8x | 13.1x |
| Forward P/E multiples | 10.5x - 17.3x | 14.6x |
| Fair Price | (4.54) - (6.70) | (5.92) |
| Upside | -161.1% - -190.1% | -179.6% |
| Date | EV/EBITDA |
| 2026-09-11 | -17.20 |
| 2026-09-10 | -16.79 |
| 2026-09-09 | -17.08 |
| 2026-09-08 | -17.25 |
| 2026-09-04 | -17.81 |
| 2026-09-03 | -17.91 |
| 2026-09-02 | -17.59 |
| 2026-09-01 | -17.22 |
| 2026-08-31 | -17.40 |
| 2026-08-28 | -17.44 |
| 2026-08-27 | -18.03 |
| 2026-08-26 | -18.59 |
| 2026-08-25 | -18.25 |
| 2026-08-24 | -17.98 |
| 2026-08-21 | -18.05 |
| 2026-08-20 | -18.64 |
| 2026-08-19 | -17.95 |
| 2026-08-18 | -16.96 |
| 2026-08-17 | -16.47 |
| 2026-08-14 | -15.38 |
| 2026-08-13 | -16.32 |
| 2026-08-12 | -17.20 |
| 2026-08-11 | -17.22 |
| 2026-08-10 | -17.57 |
| 2026-08-07 | -18.13 |
| 2026-08-06 | -17.35 |
| 2026-08-05 | -17.30 |
| 2026-08-04 | -16.42 |
| 2026-08-03 | -16.62 |
| 2026-07-31 | -15.79 |
| 2026-07-30 | -14.99 |
| 2026-07-29 | -13.79 |
| 2026-07-28 | -13.99 |
| 2026-07-27 | -13.72 |
| 2026-07-24 | -13.67 |
| 2026-07-23 | -14.01 |
| 2026-07-22 | -13.48 |
| 2026-07-21 | -13.89 |
| 2026-07-20 | -12.87 |
| 2026-07-17 | -12.58 |
| 2026-07-16 | -12.58 |
| 2026-07-15 | -12.99 |
| 2026-07-14 | -12.99 |
| 2026-07-13 | -13.11 |
| 2026-07-10 | -13.48 |
| 2026-07-09 | -13.99 |
| 2026-07-08 | -14.06 |
| 2026-07-07 | -13.94 |
| 2026-07-06 | -14.16 |
| 2026-07-02 | -14.26 |